ModraDoc006/r
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for ModraDoc006/r, covering 2021-10-19 to 2024-04-17. Get the full timeline:
Most recent: Clinical Trial Update: ModraDoc006/r vs Docetaxel IV in Metastatic Prostate Cancer [Phase 2]